|Suppression of antitumor immunity by IL-10 and TGF-β-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ …|
AG Jarnicki, J Lysaght, S Todryk, KHG Mills
The journal of immunology 177 (2), 896-904, 2006
|Lipoxygenase metabolism: roles in tumor progression and survival|
GP Pidgeon, J Lysaght, S Krishnamoorthy, JV Reynolds, K O’Byrne, D Nie, ...
Cancer and Metastasis Reviews 26 (3), 503-524, 2007
|Visceral obesity, metabolic syndrome, insulin resistance and cancer|
SL Doyle, CL Donohoe, J Lysaght, JV Reynolds
Proceedings of the Nutrition Society 71 (1), 181-189, 2012
|Nanomedicine applied to translational oncology: a future perspective on cancer treatment|
L Bregoli, D Movia, JD Gavigan-Imedio, J Lysaght, J Reynolds, ...
Nanomedicine: Nanotechnology, Biology and Medicine 12 (1), 81-103, 2016
|Obesity and gastrointestinal cancer|
CL Donohoe, GP Pidgeon, J Lysaght, JV Reynolds
British Journal of Surgery 97 (5), 628-642, 2010
|Obesity and post‐operative complications in patients undergoing non‐bariatric surgery|
SL Doyle, J Lysaght, JV Reynolds
obesity reviews 11 (12), 875-886, 2010
|IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesity|
SL Doyle, CL Donohoe, SP Finn, JM Howard, FE Lithander, JV Reynolds, ...
American Journal of Gastroenterology 107 (2), 196-204, 2012
|Establishing computed tomography–defined visceral fat area thresholds for use in obesity-related cancer research|
SL Doyle, AM Bennett, CL Donohoe, AM Mongan, JM Howard, ...
Nutrition Research 33 (3), 171-179, 2013
|Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention|
MC Cathcart, J Lysaght, GP Pidgeon
Cancer and Metastasis Reviews, 1-23, 2011
|Emerging concepts linking obesity with the hallmarks of cancer|
CL Donohoe, J Lysaght, J O'Sullivan, JV Reynolds
Trends in Endocrinology & Metabolism 28 (1), 46-62, 2017
|Pro-inflammatory and tumour proliferative properties of excess visceral adipose tissue|
J Lysaght, EP van der Stok, EH Allott, R Casey, CL Donohoe, JM Howard, ...
Cancer Letters, 2011
|Alterations in DNA repair efficiency are involved in the radioresistance of esophageal adenocarcinoma|
N Lynam-Lennon, JV Reynolds, GP Pidgeon, J Lysaght, L Marignol, ...
Radiation research 174 (6a), 703-711, 2010
|Targeting T cell immunometabolism for cancer immunotherapy; understanding the impact of the tumor microenvironment|
MB Mockler, MJ Conroy, J Lysaght
Frontiers in oncology 4, 107, 2014
|The esophagitis to adenocarcinoma sequence; the role of inflammation|
ME Kavanagh, KE O’Sullivan, C O’Hanlon, JN O’Sullivan, J Lysaght, ...
Cancer letters 345 (2), 182-189, 2014
|Role of the insulin‐like growth factor 1 axis and visceral adiposity in oesophageal adenocarcinoma|
CL Donohoe, SL Doyle, S McGarrigle, MC Cathcart, E Daly, A O'Grady, ...
British Journal of Surgery, 2012
|Heat shock protein derived from a non‐autologous tumour can be used as an anti‐tumour vaccine|
DG Casey, J Lysaght, T James, A Bateman, AA Melcher, SM Todryk
Immunology 110 (1), 105-111, 2003
|The role of inflammation in cancer of the esophagus|
KE O’Sullivan, JJ Phelan, C O’Hanlon, J Lysaght, JN O’Sullivan, ...
Expert review of gastroenterology & hepatology 8 (7), 749-760, 2014
|Obesity and gastrointestinal cancer: the interrelationship of adipose and tumour microenvironments|
J O’Sullivan, J Lysaght, CL Donohoe, JV Reynolds
Nature Reviews Gastroenterology & Hepatology 15 (11), 699-714, 2018
|Anti-cancer effects of baicalein in non-small cell lung cancer in-vitro and in-vivo|
MC Cathcart, Z Useckaite, C Drakeford, V Semik, J Lysaght, K Gately, ...
BMC cancer 16 (1), 1-13, 2016
|Impact of the inflammatory microenvironment on T-cell phenotype in the progression from reflux oesophagitis to Barrett oesophagus and oesophageal adenocarcinoma|
ME Kavanagh, MJ Conroy, NE Clarke, NT Gilmartin, KE O'Sullivan, ...
Cancer letters 370 (1), 117-124, 2016